Optimized rehabilitation for breast cancer survivors after surgery
Optimized Rehabilitation Following Primary Breast Cancer Surgery - Systematic Screening as a Tool for Individualised Rehabilitation: Study Protocol for the RE-SCREEN Randomized Controlled Trial
This study tests a personalized rehabilitation program for breast cancer survivors after surgery to see if it helps improve their mental and physical health while also understanding their support needs.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 643 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Lund University Academic / other |
| Locations | 1 site (Malmö) |
| Trial ID | NCT03434717 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of an individualized rehabilitation intervention for breast cancer survivors, focusing on systematic screening of psychological distress to tailor support and rehabilitation. It aims to address the psychological, physical, and health-economic outcomes of patients following primary breast cancer surgery. Additionally, the study seeks to understand the experiences and support needs of patients and their relatives during the rehabilitation process.
Who should consider this trial
Good fit: Ideal candidates are individuals who have undergone treatment for primary breast cancer and are 18 years or older.
Not a fit: Patients with recurrent disease, palliative diagnoses, or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide personalized rehabilitation strategies that significantly improve the quality of life for breast cancer survivors.
How similar studies have performed: While numerous studies have explored rehabilitation for breast cancer survivors, this approach of individualized support based on psychological distress screening is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Undergone treatment for primary breast cancer * ≤18 years old * Ability to communicate in Swedish * Written informed consent Exclusion Criteria: * Recurrent disease * Palliative diagnosis * Pregnancy * Prior history of breast cancer * Inability to participate in the study due to cognitive impairment
Where this trial is running
Malmö
- Skåne university hospital — Malmö, Sweden (Recruiting)
Study contacts
- Principal investigator: Marlene Malmström, PhD — Lund university, department of health siences, Lund
- Study coordinator: Marlene Malmström, Ass professor
- Email: marlene.malmstrom@med.lu.se
- Phone: +4646175950
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.